Aurobindo Pharma LtdNSE: AUROPHARMA

Press Release May 03 2022

· Issued by Aurobindo Pharma Ltd

Aurobindo Pharma Limited has informed the Exchange about press release dated 03-May-2022 titled Press Release on USFDA approval for Bortezomib for Injection received by Eugia Pharma

View Attachment